Jab Forest B.v. is Buying Panera Bread Co (NASDAQ:PNRA) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Panera Bread Co (NASDAQ:PNRA) reported that Jab Forest B.v. has picked up 75,524 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Jab Forest B.v. to a total of 75,524 representing a 0.35% stake in the company.
For those not familiar with the company, Panera Bread Company is a food service company. The Company is a national bakery-cafe concept. As of December 27, 2016, the Company operated 2,036 own and franchise-operated bakery-cafe locations in 46 states, the District of Columbia, and Ontario, Canada. It operates through three segments: Company bakery-cafe operations, franchise operations, and fresh dough and other product operations. The Company Bakery-Cafe Operations segment includes the operating activities of the bakery-cafes owned directly and indirectly by the Company. The Franchise Operations segment includes the operating activities of the franchise business unit, which licenses qualified operators to conduct business under the Panera Bread or Paradise Bakery & Cafe names. The Fresh Dough and Other Product Operations segment supplies fresh dough, produce, tuna, cream cheese, and indirectly supplies sweet goods items through a contract manufacturing arrangement, to the Company-owned and franchise-operated bakery-cafes.
A glance at Panera Bread Co (NASDAQ:PNRA)’s key stats reveals a current market capitalization of 7.20 Billion based on 21.58 Million shares outstanding and a price at last close of $315.44 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2013-07-26, Matthews picked up 1,500 at a purchase price of $168.58. This brings their total holding to 4,893 as of the date of the filing.
On the sell side, the most recent transaction saw Moreton unload 1,974 shares at a sale price of $232.13. This brings their total holding to 9,874.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Panera Bread Co (NASDAQ:PNRA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Wl Ross Sponsor Picked Nexeo Solutions Inc. (NASDAQ:NXEO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Nexeo Solutions Inc. (NASDAQ:NXEO) reported that Wl Ross Sponsor Llc. has picked up 2,280,860 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Wl Ross Sponsor Llc. to a total of 2,280,860 representing a 2.6% stake in the company.
For those not familiar with the company, Nexeo Solutions Inc, formerly WL Ross Holding Corp., is global distributor of chemicals products in North America and Asia, and plastics products in North America, Europe, the Middle East and Africa (EMEA) and Asia. The Company provides services, such as custom blending, packaging and re-packaging, private-label manufacturing and product testing in the form of chemical analysis, product performance analysis and product development. It also provides environmental services, including waste collection, recovery and arrangement for disposal services and recycling in North America, primarily in the United States, through its Environmental Services line of business. The Company operates in three segments: Chemicals, Plastics and Environmental Services.
A glance at Nexeo Solutions Inc. (NASDAQ:NXEO)’s key stats reveals a current market capitalization of 780.47 Million based on 89.29 Million shares outstanding and a price at last close of $8.84 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-14, Zatta picked up 1,000 at a purchase price of $9.06. This brings their total holding to 1,000 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Nexeo Solutions Inc. (NASDAQ:NXEO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
United Insurance Holdings Corp. (NASDAQ:UIHC) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), United Insurance Holdings Corp. (NASDAQ:UIHC) reported that Peed Leah Anneberg has picked up 3,487,837 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Peed Leah Anneberg to a total of 3,487,837 representing a 8.2% stake in the company.
For those not familiar with the company, United Insurance Holdings Corp. is a property and casualty insurance holding company that sources, writes and services residential property and casualty insurance policies using a network of agents and a group of insurance subsidiaries. The Company’s insurance subsidiary is United Property & Casualty Insurance Company. Its other subsidiaries include United Insurance Management, L.C., the managing general agent that manages substantially all aspects of United Property & Casualty Insurance Company’s business; Skyway Claims Services, LLC, which provides services to its insurance affiliate; UPC Re, which provides a portion of the reinsurance protection purchased by its insurance affiliate. The Company’s principal product is homeowners’ insurance, which it offers in Connecticut, Florida, Georgia, Hawaii, Louisiana, Massachusetts, New Jersey, North Carolina, Rhode Island, South Carolina and Texas.
A glance at United Insurance Holdings Corp. (NASDAQ:UIHC)’s key stats reveals a current market capitalization of 321.58 Million based on 21.73 Million shares outstanding and a price at last close of $14.93 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-10, Hood picked up 41,658 at a purchase price of $17.01. This brings their total holding to 689,191 as of the date of the filing.
On the sell side, the most recent transaction saw Whittemore unload 4,500 shares at a sale price of $17.79. This brings their total holding to 236,127.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on United Insurance Holdings Corp. (NASDAQ:UIHC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Angiodynamics Inc. (NASDAQ:ANGO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Angiodynamics Inc. (NASDAQ:ANGO) reported that Avista Capital Partners Gp, Llc. has picked up 2,333,008 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Avista Capital Partners Gp, Llc. to a total of 2,333,008 representing a 6.3% stake in the company.
For those not familiar with the company, AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company’s Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company’s BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.
A glance at Angiodynamics Inc. (NASDAQ:ANGO)’s key stats reveals a current market capitalization of 558.82 Million based on 36.79 Million shares outstanding and a price at last close of $15.19 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-04-14, Kapusta picked up 1,000 at a purchase price of $13.90. This brings their total holding to 27,005 as of the date of the filing.
On the sell side, the most recent transaction saw Burgstahler unload 384,184 shares at a sale price of $16.00. This brings their total holding to 381,406.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Angiodynamics Inc. (NASDAQ:ANGO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Eco-Stim Energy Solutions Inc. (NYSE:ESES) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Eco-Stim Energy Solutions Inc. (NYSE:ESES) reported that Bienville Argentina Opportunities Master Fund, Lp. has picked up 1,507,696 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Bienville Argentina Opportunities Master Fund, Lp. to a total of 1,507,696 representing a 10.0% stake in the company.
For those not familiar with the company, Eco-Stim Energy Solutions, Inc. is an oilfield services company. The Company provides well stimulation, coiled tubing and field management services to the upstream oil and gas industry. The Company focuses on the active shale and unconventional oil and natural gas basins outside the United States and it has commenced operations in Argentina. The Company operates well stimulation fleets, coiled tubing units and other downhole completion equipment, as well as provides sweet spot analysis in shale resource basins using geophysical predictive modeling combined with real-time feedback from down-hole diagnostic tools. The Company offers a pumping fleet, including well-stimulation pumps, nitrogen pumping units and cranes, in both trailer-mounted and skid-mounted configurations. It provides a range of pressure-pumping services, including work-over pumping, well injection and wireline pump downs.
A glance at Eco-Stim Energy Solutions Inc. (NYSE:ESES)’s key stats reveals a current market capitalization of 17.46 Million based on 20.59 Million shares outstanding and a price at last close of $1.16 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-09-22, Bienville picked up 50,874 at a purchase price of $2.28. This brings their total holding to 2,979,534 as of the date of the filing.
On the sell side, the most recent transaction saw Bass unload 1,530,678 shares at a sale price of $1.21. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Eco-Stim Energy Solutions Inc. (NYSE:ESES) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Neos Therapeutics Inc. (NASDAQ:NEOS) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Neos Therapeutics Inc. (NASDAQ:NEOS) reported that Dammeyer Rodney F has picked up 1,001,568 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Dammeyer Rodney F to a total of 1,001,568 representing a 6.2% stake in the company.
For those not familiar with the company, Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to develop its product for the treatment of attention deficit hyperactivity disorder (ADHD). Its product candidates are extended-release (XR), medications in patient-friendly, orally disintegrating tablets (ODT) or liquid suspension dosage forms. Its branded product and product candidates incorporate over two of the prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Its modified-release drug delivery platform has enabled it to create extended-release ODT and liquid suspension dosage forms of the medications. It focuses on developing Adzenys XR-ODT, Cotempla XR-ODT and NT-0201.
A glance at Neos Therapeutics Inc. (NASDAQ:NEOS)’s key stats reveals a current market capitalization of 152.29 Million based on 22.56 Million shares outstanding and a price at last close of $6.80 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-08-31, Fong picked up 1,500 at a purchase price of $6.54. This brings their total holding to 1,500 as of the date of the filing.
On the sell side, the most recent transaction saw Presidio unload 213 shares at a sale price of $9.88. This brings their total holding to 39,998.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Neos Therapeutics Inc. (NASDAQ:NEOS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Uluru Inc. (OTCMKTS:ULUR) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Uluru Inc. (OTCMKTS:ULUR) reported that Sacks Michael Ivan has picked up 43,711,970 of common stock as of 2017-04-13.
The acquisition brings the aggregate amount owned by Sacks Michael Ivan to a total of 43,711,970 representing a 48.4% stake in the company.
For those not familiar with the company, ULURU Inc. is a specialty pharmaceutical company focused on developing and commercializing a range of wound care and muco-adhesive film products based on its Nanoflex and OraDisc technologies for patients, healthcare professionals and healthcare payers. The Company operates through the research, development and commercialization of pharmaceutical products segment. Utilizing its technologies, three of its products have been approved for marketing in various global markets. Altrazeal Transforming Powder Dressing is based on its Nanoflex technology, which changes the way healthcare providers approach their treatment of wounds. The product is indicated for both exuding acute wounds, such as donor sites, non-healing surgical wounds, and trauma and for chronic wounds, such as venous leg ulcers, diabetic foot ulcers and pressure ulcers. Aphthasol is a drug approved for the treatment of canker sores. OraDisc is developed as an improved drug delivery system for the treatment of canker sores.
A glance at Uluru Inc. (OTCMKTS:ULUR)’s key stats reveals a current market capitalization of 4.26 Million based on 62.97 Million shares outstanding and a price at last close of $0.0677 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-29, Wallberg picked up 701,262 at a purchase price of $0.07. This brings their total holding to 825,519 as of the date of the filing.
On the sell side, the most recent transaction saw Oss unload 3,400,000 shares at a sale price of $0.16. This brings their total holding to 8,061,522.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Uluru Inc. (OTCMKTS:ULUR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Lytton Laurence is Buying Catalyst Biosciences (NASDAQ:CBIO) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Catalyst Biosciences Inc. (NASDAQ:CBIO) reported that Lytton Laurence W has picked up 220,500 of common stock as of 2017-04-13.
The acquisition brings the aggregate amount owned by Lytton Laurence W to a total of 220,500 representing a 8.1% stake in the company.
For those not familiar with the company, Catalyst Biosciences, Inc., formerly Targacept, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on creating and developing medicines to address serious medical conditions. The Company focuses its product development efforts in the fields of hemostasis, including the treatment of hemophilia and surgical bleeding, and inflammation, including prevention of delayed graft function (DGF) in renal transplants and the treatment of dry age-related macular degeneration (dry AMD), a condition that can cause visual impairment or blindness. The Company’s advanced program is a coagulation Factor VIIa variant, CB 813d, that has completed a Phase I clinical trial in severe hemophilia A and B patients. In addition to its lead Factor VIIa program, it has approximately two other coagulation factors, a Factor IX variant, CB 2679d/ISU 304, that is in advanced preclinical development, and a Factor Xa variant that has reached the advanced lead preclinical-stage of development.
A glance at Catalyst Biosciences Inc. (NASDAQ:CBIO)’s key stats reveals a current market capitalization of 5.00 Million based on 1.00 Million shares outstanding and a price at last close of $5.41 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-12-17, Usman picked up 4,000 at a purchase price of $2.00. This brings their total holding to 78,375 as of the date of the filing.
On the sell side, the most recent transaction saw Barris unload 1,000 shares at a sale price of $5.13. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Catalyst Biosciences Inc. (NASDAQ:CBIO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.